History and Prospects of Drug Discovery and Development Collaboration between Industry and Academia,Journal of Natural Products

当前位置： X-MOL 学术 › J. Nat. Prod. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

History and Prospects of Drug Discovery and Development Collaboration between Industry and Academia
Journal of Natural Products ( IF 3.3 ) Pub Date : 2024-03-30 , DOI: 10.1021/acs.jnatprod.4c00081
Sheo B Singh _{1,

2} , Gary E Martin ₂ , Brian McKittrick ₁ , Jonathan Crowther ₁ , Howard Fraenkel ₁ , Charles Lunn ₁ , Marvin Bayne ₁ , John B Perkins ₁ , Vincent Gullo ₁

Affiliation

Research collaborations and licensing deals are critical for the discovery and development of life-saving drugs. This practice has been ongoing since the inception of the pharmaceutical industry. The current process of drug discovery and development is complex, regulated, and highly regimented, having evolved over time. Academia excels in the discovery of fundamental scientific concepts and biological processes, while industry excels in translational science and product development. Potential for collaboration exists at every step of the drug discovery and development continuum. This perspective walks through such collaborative activities, provides examples, and offers tips for potential collaborations.

中文翻译：

产学界药物发现和开发合作的历史和前景

研究合作和许可交易对于发现和开发救生药物至关重要。自制药行业诞生以来，这种做法一直在持续。当前的药物发现和开发过程是复杂的、受监管的、高度管制的，并且随着时间的推移而不断发展。学术界擅长发现基本科学概念和生物过程，而工业界则擅长转化科学和产品开发。药物发现和开发过程的每一步都存在合作潜力。这个视角将介绍此类协作活动，提供示例并提供潜在协作的技巧。

更新日期：2024-03-30

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南